{"nct_id":"NCT01581138","title":"VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C","status":"COMPLETED","status_verified_date":"2014-07","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2013-06","primary_completion_date_type":"ACTUAL","completion_date":"2013-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["VRTX"]}